alto ingredients - ALTO

ALTO

Close Chg Chg %
4.79 -0.12 -2.51%

Closed Market

4.67

-0.12 (2.51%)

Volume: 1.41M

Last Updated:

Apr 2, 2026, 4:00 PM EDT

Company Overview: alto ingredients - ALTO

ALTO Key Data

Open

$4.71

Day Range

4.47 - 4.72

52 Week Range

0.76 - 5.06

Market Cap

$360.96M

Shares Outstanding

77.29M

Public Float

67.46M

Beta

0.06

Rev. Per Employee

N/A

P/E Ratio

29.26

EPS

$0.16

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

2.93M

 

ALTO Performance

1 Week
 
3.55%
 
1 Month
 
6.38%
 
3 Months
 
75.56%
 
1 Year
 
416.94%
 
5 Years
 
-17.49%
 

ALTO Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 2
Full Ratings ➔

About alto ingredients - ALTO

Alto Ingredients, Inc. engages in the production and marketing of specialty alcohols and essential ingredients. It operates through the following segments: Marketing and Distribution, Pekin Production, and Western Production. The Marketing and Distribution segment includes marketing and merchant trading for company-produced alcohols and essential ingredients, on an aggregated basis, and third-party fuel-grade ethanol. The Pekin Campus Production segment deals with the production and sale of alcohols and essential ingredients produced at the company's Pekin, Illinois campus. The Western Production segment covers the production and sale of renewable fuel and essential ingredients produced at two western production facilities. The company was founded by William L. Jones and Neil M. Koehler on January 30, 2003, and is headquartered in Pekin, IL.

ALTO At a Glance

Alto Ingredients, Inc.
1300 South Second Street
Pekin, Illinois 61554
Phone 1-833-710-2586 Revenue 917.93M
Industry Chemicals: Specialty Net Income 13.34M
Sector Process Industries Employees 390
Fiscal Year-end 12 / 2026
View SEC Filings

ALTO Valuation

P/E Current 29.261
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 18.045
Price to Sales Ratio 0.237
Price to Book Ratio 0.908
Price to Cash Flow Ratio 16.45
Enterprise Value to EBITDA 8.959
Enterprise Value to Sales 0.316
Total Debt to Enterprise Value 0.337

ALTO Efficiency

Revenue/Employee 2,353,658.974
Income Per Employee 34,200.00
Receivables Turnover 14.671
Total Asset Turnover 2.317

ALTO Liquidity

Current Ratio 2.639
Quick Ratio 1.595
Cash Ratio 0.435

ALTO Profitability

Gross Margin 2.925
Operating Margin 0.778
Pretax Margin 1.385
Net Margin 1.453
Return on Assets 3.367
Return on Equity 5.672
Return on Total Capital 3.89
Return on Invested Capital 4.065

ALTO Capital Structure

Total Debt to Total Equity 39.796
Total Debt to Total Capital 28.467
Total Debt to Total Assets 25.073
Long-Term Debt to Equity 31.006
Long-Term Debt to Total Capital 22.179
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Alto Ingredients - ALTO

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
1.34B 1.22B 965.26M 917.93M
Sales Growth
+10.57% -8.44% -21.07% -4.90%
Cost of Goods Sold (COGS) incl D&A
1.38B 1.20B 966.58M 891.08M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
25.09M 23.08M 24.41M 25.22M
Depreciation
24.53M 22.49M 23.82M 24.59M
Amortization of Intangibles
567.00K 588.00K 588.00K 621.00K
COGS Growth
+19.00% -13.25% -19.40% -7.81%
Gross Income
(46.81M) 23.68M (1.32M) 26.84M
Gross Income Growth
-201.40% +150.59% -105.59% +2,129.10%
Gross Profit Margin
-3.50% +1.94% -0.14% +2.92%
2022 2023 2024 2025 5-year trend
SG&A Expense
31.58M 32.66M 29.74M 27.21M
Research & Development
- - - -
-
Other SG&A
31.58M 32.66M 29.74M 27.21M
SGA Growth
+8.20% +3.44% -8.96% -8.50%
Other Operating Expense
- - - (7.50M)
-
Unusual Expense
4.02M 16.22M 18.92M (3.67M)
EBIT after Unusual Expense
(82.41M) (25.20M) (49.98M) 10.80M
Non Operating Income/Expense
44.56M 4.72M (1.19M) 12.68M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
1.83M 7.42M 7.64M 10.77M
Interest Expense Growth
-49.07% +306.40% +2.95% +40.83%
Gross Interest Expense
1.83M 7.42M 7.64M 10.80M
Interest Capitalized
- - - 30.30K
-
Pretax Income
(39.67M) (27.91M) (58.81M) 12.72M
Pretax Income Growth
-183.43% +29.65% -110.73% +121.62%
Pretax Margin
-2.97% -2.28% -6.09% +1.39%
Income Tax
1.93M 97.00K 173.00K (621.00K)
Income Tax - Current - Domestic
1.93M 97.00K 173.00K (621.00K)
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(41.60M) (28.00M) (58.98M) 13.34M
Minority Interest Expense
- - - -
-
Net Income
(41.60M) (28.00M) (58.98M) 13.34M
Net Income Growth
-191.46% +32.68% -110.62% +122.61%
Net Margin Growth
-3.11% -2.29% -6.11% +1.45%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(41.60M) (28.00M) (58.98M) 13.34M
Preferred Dividends
1.26M 1.26M 1.27M 1.26M
Net Income Available to Common
(42.86M) (29.27M) (60.25M) 12.07M
EPS (Basic)
-0.5958 -0.3991 -0.82 0.162
EPS (Basic) Growth
-195.80% +33.01% -105.46% +119.76%
Basic Shares Outstanding
71.94M 73.34M 73.48M 74.51M
EPS (Diluted)
-0.5958 -0.3991 -0.82 0.1596
EPS (Diluted) Growth
-197.31% +33.01% -105.46% +119.46%
Diluted Shares Outstanding
71.94M 73.34M 73.48M 75.66M
EBITDA
(53.30M) 14.10M (6.65M) 32.35M
EBITDA Growth
-232.34% +126.46% -147.17% +586.44%
EBITDA Margin
-3.99% +1.15% -0.69% +3.52%

Snapshot

Average Recommendation BUY Average Target Price 4.25
Number of Ratings 2 Current Quarters Estimate 0.08
FY Report Date 06 / 2026 Current Year's Estimate 0.23
Last Quarter’s Earnings -0.045 Median PE on CY Estimate N/A
Year Ago Earnings 0.16 Next Fiscal Year Estimate 0.35
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 2 2 1
Mean Estimate 0.08 0.09 0.23 0.35
High Estimates 0.09 0.14 0.27 0.35
Low Estimate 0.07 0.04 0.19 0.35
Coefficient of Variance 17.68 78.57 24.60 N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 2
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Alto Ingredients in the News